Lenacapavir Manufacturing In SA: Strengthening Production
Lenacapavir manufacturing in SA aims to strengthen supply chains and provide critical HIV prevention solutions.
HIV Prevention Shot Lenacapavir: Aspen Warns of Demand Risks
Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.
Lenacapavir HIV Prevention Injection to Reach Too Few
South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan…. Membership Required You must be a member to access this...
Human HIV Vaccine Trial Begins With BRILLIANT 011
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
2026 Healthcare Watchlist: Nine Healthcare Stories to Track
Spotlight’s 2026 Healthcare Watchlist highlights nine health topics, from a new HIV prevention jab to NHI court battles and aid shocks.
HIV Prevention in SA Needs Local Lenacapavir Manufacturing
HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
Generic Lenacapavir Manufacturing: SA’s Bold 2027 Strategy
South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.
Lenacapavir in Short Supply Amid HIV Epidemic in Africa
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
Lenacapavir Approved for HIV Prevention in South Africa
Lenacapavir has been registered by SAHPRA as an innovative HIV prevention injection. Find out more about its rollout in South Africa.
HIV Funding Boost Revealed by Health Minister Motsoaledi
South Africa receives a significant R2 billion HIV funding boost from the US CDC to sustain crucial health initiatives.